通过巨细胞传递CD52信号的Siglec-G代表了癌症免疫治疗的治疗标
Xueting Qin1,2, Yixin Chang2, Yuanyuan Qiu3
1School of Medicine, Nankai University, Tianjin, China.
NPJ breast cancer
|January 24, 2026
概括
研究人员确定CD52是三阴性乳腺癌 (TNBC) 中的一种新的"不要吃我"信号. 阻止CD52可恢复巨细胞对癌细胞的清除,为TNBC提供一种新的免疫治疗策略.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 细胞生物学 细胞生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 具有侵略性,治疗选择有限.
- 癌细胞使用"不要吃我"信号来逃避像巨细胞这样的免疫细胞.
- 针对这些信号的现有疗法具有可变的疗效,这表明存在未知的机制.
研究的目的:
- 在TNBC中识别新的抗菌细胞检查点.
- 调查CD52在TNBC免疫逃避中的作用.
- 评估针对CD52-Siglec-G轴的治疗潜力.
主要方法:
- 在TNBC患者瘤中检测到CD52表达.
- 利用基因切除和对CD52和Siglec-G.抗体的阻断.
- 在体外和体内评估了巨细胞的细胞活性.
- 在TNBC小鼠模型中评估瘤进展,生存和免疫微环境.
- 测试了用抗CD52和PD-1阻断的组合疗法.
主要成果:
- CD52在TNBC细胞上表达,并在巨细胞上激活Siglec-G,抑制细胞化.
- 阻断CD52或Siglec-G恢复了巨细胞化,抑制了瘤生长,并在TNBC模型中改善了生存率.
- 向CD52促进了免疫学上活跃的瘤微环境.
- 结合抗CD52和PD-1阻断在自发TNBC模型中增强了治疗疗效.
结论:
- CD52是TNBC的关键抗细胞检查点,有助于免疫逃避.
- 向CD52-Siglec-G通路为TNBC提供了一个有前途的治疗策略.
- 双重PD-1/CD52阻塞是一种新且潜在有效的TNBC免疫疗法.
相关概念视频
The Representativeness Heuristic
16.7K
The representative heuristic describes a biased way of thinking, in which you unintentionally stereotype someone or something. For example, you may assume that your professors spend their free time reading books and engaging in intellectual conversation, because the idea of them spending their time playing volleyball or visiting an amusement park does not fit in with your stereotypes of professors.
16.7K
Targeted Cancer Therapies
8.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.7K
mTOR Signaling and Cancer Progression
4.7K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
4.7K
Tumor Immunotherapy
1.8K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.8K
What is Cell Signaling?
129.9K
Despite the protective membrane that separates a cell from the environment, cells need the ability to detect and respond to environmental changes. Additionally, cells often need to communicate with one another. Unicellular and multicellular organisms use a variety of cell signaling mechanisms to communicate to respond to the environment.
129.9K
Endocrine Signaling
68.0K
Endocrine cells produce hormones to communicate with remote target cells found in other organs. The hormone reaches these distant areas using the circulatory system. This exposes the whole organism to the hormone but only those cells expressing hormone receptors or target cells are affected. Thus, endocrine signaling induces slow responses from its target cells but these effects also last longer.
68.0K


